Rxivist logo

Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours

By Bhavya Dhaka, Radhakrishnan Sabarinathan

Posted 24 Nov 2020
bioRxiv DOI: 10.1101/2020.11.24.395913

Mutations in TP53 not only affect its tumour suppressor activity but also exerts oncogenic gain-of-function activity. While the genome-wide mutant p53 binding sites have been identified in cancer cell lines, the chromatin accessibility landscape driven by mutant p53 in primary tumours is unknown. Here, we leveraged the chromatin accessibility data of primary tumours from TCGA to identify differentially accessible regions in mutant p53 tumours compared to wild p53 tumours, especially in breast and colon cancers. We found 1587 lost and 984 gained accessible regions in breast, and 1143 lost and 640 gained regions in colon. However, less than half of those regions in both cancer types contain sequence motifs for wild-type or mutant p53 binding. Whereas, the remaining showed enrichment for master transcriptional regulators, such as FOX-Family TFs and NF-kB in lost and SMAD and KLF TFs in gained regions of breast. In colon, ATF3 and FOS/JUN TFs were enriched in lost, and CDX family TFs and HNF4A in gained regions. By integrating the gene expression data, we identified known and novel target genes regulated by the mutant p53. Together, these results suggest the tissue- and tumour-type specific role of mutant p53 in regulating chromatin structure and gene expression.

Download data

  • Downloaded 489 times
  • Download rankings, all-time:
    • Site-wide: 74,776
    • In genomics: 5,044
  • Year to date:
    • Site-wide: 43,980
  • Since beginning of last month:
    • Site-wide: 56,616

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide